series-c-plus
Stage
1
Investors
About
Ovid Therapeutics is a biopharmaceutical company developing therapies for rare neurological disorders, with clinical-stage programs targeting certain genetic epilepsies and neurodevelopmental conditions such as Angelman syndrome.
Explore Ovid Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.